Glycemic Control as an Early Prognostic Marker in Advanced Pancreatic Cancer
Alpertunga I, Sadiq R, Pandya D, Lo T, Dulgher M, Evans S, Bennett B, Rennert N, Frank R. Glycemic Control as an Early Prognostic Marker in Advanced Pancreatic Cancer. Frontiers In Oncology 2021, 11: 571855. PMID: 33718132, PMCID: PMC7947820, DOI: 10.3389/fonc.2021.571855.Peer-Reviewed Original ResearchAdvanced pancreatic ductal adenocarcinomaPancreatic ductal adenocarcinomaImproved overall survivalOverall survivalGlycemic controlCA 19Serum tumor markers CA 19Cox proportional hazards regression modelProportional hazards regression modelsTumor marker CA 19Random blood glucose valuesEarly glycemic controlAdvanced pancreatic cancerPresence of diabetesCohort of patientsMonths of treatmentEarly prognostic markerImpaired glucose metabolismLog-rank testHazards regression modelsKaplan-Meier estimatesLarge patient cohortNovel prognostic biomarkerBlood glucose valuesLow glucose levels